21 de enero de 2027
FDA PDUFA target action date for zeleciment rostudirsen (DYNE-251), a BLA from Dyne Therapeutics. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
Calendario de Fechas de decisión PDUFA de la FDA